Kenneth Abrams

5.3k total citations · 1 hit paper
80 papers, 3.3k citations indexed

About

Kenneth Abrams is a scholar working on Experimental and Cognitive Psychology, Hematology and Rheumatology. According to data from OpenAlex, Kenneth Abrams has authored 80 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Experimental and Cognitive Psychology, 23 papers in Hematology and 18 papers in Rheumatology. Recurrent topics in Kenneth Abrams's work include Autoimmune and Inflammatory Disorders Research (23 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (22 papers) and Behavioral Health and Interventions (11 papers). Kenneth Abrams is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (23 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (22 papers) and Behavioral Health and Interventions (11 papers). Kenneth Abrams collaborates with scholars based in United States, Switzerland and Italy. Kenneth Abrams's co-authors include Matt G. Kushner, Peter Mesenbrink, Steven Boonen, Erik Fink Eriksen, Lars Hyldstrup, Jie Zhang, John J. Orloff, Kenneth W. Lyles, Jonathan D. Adachi and C. Mautalén and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Spine.

In The Last Decade

Kenneth Abrams

79 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

2007 1.4k citations Kenneth W. Lyles, Cathleen Colón‐Emeric et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kenneth Abrams United States	27	1.3k	900	680	572	485	80	3.3k
Joe C. Christian United States	30	1.7k 1.3×	385 0.4×	496 0.7×	889 1.6×	99 0.2×	73	4.1k
Jill Santanna United States	13	281 0.2×	179 0.2×	252 0.4×	565 1.0×	250 0.5×	13	3.4k
Francesco Masedu Italy	27	147 0.1×	380 0.4×	326 0.5×	194 0.3×	360 0.7×	118	2.3k
Costantino Di Carlo Italy	36	349 0.3×	300 0.3×	453 0.7×	364 0.6×	73 0.2×	197	4.4k
William J. Culpepper United States	24	179 0.1×	227 0.3×	839 1.2×	241 0.4×	107 0.2×	61	3.2k
Deborah Miller United States	32	116 0.1×	416 0.5×	133 0.2×	215 0.4×	257 0.5×	84	3.9k
Véronique Breuil France	28	535 0.4×	389 0.4×	496 0.7×	669 1.2×	14 0.0×	87	2.5k
Steven M. Willi United States	41	180 0.1×	235 0.3×	2.1k 3.1×	805 1.4×	95 0.2×	123	5.9k
Dave H. Schweitzer Netherlands	30	285 0.2×	267 0.3×	753 1.1×	228 0.4×	1.1k 2.2×	77	3.1k
Andrew G. Bushmakin United States	33	50 0.0×	268 0.3×	310 0.5×	413 0.7×	308 0.6×	155	3.6k

Countries citing papers authored by Kenneth Abrams

Since Specialization

Citations

This map shows the geographic impact of Kenneth Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth Abrams more than expected).

Fields of papers citing papers by Kenneth Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth Abrams. The network helps show where Kenneth Abrams may publish in the future.

Co-authorship network of co-authors of Kenneth Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth Abrams. A scholar is included among the top collaborators of Kenneth Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth Abrams. Kenneth Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mansueto, Giovanni, Danilo Carrozzino, Kaj Sparle Christensen, et al.. (2021). Clinimetric properties of the Smoking Abstinence Expectancies Questionnaire. Addictive Behaviors. 123. 107061–107061. 11 indexed citations

Quartier, Pierre, Е.I. Alexeeva, Tamás Constantin, et al.. (2020). Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized Study. Arthritis & Rheumatology. 73(2). 336–346. 23 indexed citations

Kivitz, Alan, Peter Nash, Hasan Tahir, et al.. (2019). Efficacy and Safety of Subcutaneous Secukinumab 150 mg with or Without Loading Regimen in Psoriatic Arthritis: Results from the FUTURE 4 Study. Rheumatology and Therapy. 6(3). 393–407. 61 indexed citations

McInnes, Iain B., Philip J. Mease, Kristian Reich, et al.. (2019). 257 Secukinumab demonstrates a consistent safety profile with up to 5 years’ treatment in patients with psoriatic arthritis and moderate-to-severe plaque psoriasis: updated pooled safety analyses. Lara D. Veeken. 58(Supplement_3). 1 indexed citations

Mease, Philip J., Iain B. McInnes, Kristian Reich, et al.. (2017). Secukinumab Demonstrates Consistent Safety over Long-Term Exposure in Patients with Psoriatic Arthritis and Moderate to Severe Plaque Psoriasis: Updated Pooled Safety Analyses. Queensland's institutional digital repository (The University of Queensland). 69. 2149–2149. 1 indexed citations

Gattorno, Marco, Laura Obici, Marco Cattalini, et al.. (2016). Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study. Annals of the Rheumatic Diseases. 76(1). 173–178. 66 indexed citations

Abrams, Kenneth, et al.. (2016). Facilitating study abroad for psychology students. Psychology Teaching Review. 22(2). 4–15. 1 indexed citations

Grom, Alexei A., Norman T. Ilowite, Virginia Pascual, et al.. (2015). Rate and Clinical Presentation of Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Canakinumab. Arthritis & Rheumatology. 68(1). 218–228. 86 indexed citations

Gattorno, Marco, Laura Obici, Jordi Antón, et al.. (2012). Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome. UCL Discovery (University College London). 8 indexed citations

10.

Erlacher‐Reid, Claire, Carmen M. H. Colitz, Kenneth Abrams, Ainsley Smith, & Allison D. Tuttle. (2011). Bilateral Ocular Abnormalities in a Wild Stranded Harp Seal (Phoca groenlandica) Suggestive of Anterior Segment Dysgenesis and Persistent Hyperplastic Primary Vitreous. Journal of Zoo and Wildlife Medicine. 42(2). 300–303. 2 indexed citations

11.

Brett, Alan, Colin G. Miller, Curtis W. Hayes, et al.. (2009). Development of a Clinical Workflow Tool to Enhance the Detection of Vertebral Fractures. Spine. 34(22). 2437–2443. 33 indexed citations

12.

Boonen, Steven, Deborah E. Sellmeyer, Kurt Lippuner, et al.. (2008). Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women. Kidney International. 74(5). 641–648. 88 indexed citations

13.

Abrams, Kenneth, et al.. (2008). Fear reactivity to bodily sensations among heavy smokers and nonsmokers.. Experimental and Clinical Psychopharmacology. 16(3). 230–239. 17 indexed citations

14.

Kushner, Matt G., Kenneth Abrams, Christopher B. Donahue, et al.. (2007). Urge to Gamble in Problem Gamblers Exposed to a Casino Environment. Journal of Gambling Studies. 23(2). 121–132. 32 indexed citations

15.

Lyles, Kenneth W., Cathleen Colón‐Emeric, Jay Magaziner, et al.. (2007). Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture. New England Journal of Medicine. 357(18). 1799–1809. 1401 indexed citations breakdown →

16.

Rassovsky, Yuri, Kenneth Abrams, & Matt G. Kushner. (2006). Suffocation and respiratory responses to carbon dioxide and breath holding challenges in individuals with panic disorder. Journal of Psychosomatic Research. 60(3). 291–298. 29 indexed citations

17.

Abrams, Kenneth, Yuri Rassovsky, & Matt G. Kushner. (2006). Evidence for respiratory and nonrespiratory subtypes in panic disorder. Depression and Anxiety. 23(8). 474–481. 26 indexed citations

18.

Kushner, Matt G., et al.. (2005). Follow-up Study of Anxiety Disorder and Alcohol Dependence in Comorbid Alcoholism Treatment Patients. Alcoholism Clinical and Experimental Research. 29(8). 1432–1443. 174 indexed citations

19.

Abrams, Kenneth, et al.. (2001). The pharmacologic and expectancy effects of alcohol on social anxiety in individuals with social phobia. Drug and Alcohol Dependence. 64(2). 219–231. 72 indexed citations

20.

Abrams, Kenneth. (1979). CI-TAB: View for the Blind.. 11(1). 23–27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact